MIST
Milestone Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$0.77
+0.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.23x
- Price / sales
- 40.69x
- Price / cash flow
- -1.56x
Enterprise value
- Enterprise value
- $66.6M
- EV / sales
- 28.41x
- EV / EBITDA
- -0.91x
- EV / EBIT
- -0.85x
- Market cap
- $95.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026